| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Amyotrophic Lateral Sclerosis | 45 | 2023 | 182 | 8.810 |
Why?
|
| Superoxide Dismutase | 22 | 2018 | 177 | 5.370 |
Why?
|
| Theilovirus | 24 | 2019 | 39 | 4.560 |
Why?
|
| Spinal Cord | 25 | 2018 | 249 | 2.040 |
Why?
|
| Superoxide Dismutase-1 | 14 | 2019 | 48 | 1.990 |
Why?
|
| Viral Proteins | 18 | 2011 | 300 | 1.890 |
Why?
|
| Maus Elberfeld virus | 25 | 1994 | 34 | 1.750 |
Why?
|
| Demyelinating Diseases | 17 | 2011 | 68 | 1.610 |
Why?
|
| Motor Neurons | 13 | 2021 | 162 | 1.510 |
Why?
|
| Protein Biosynthesis | 11 | 2022 | 378 | 1.330 |
Why?
|
| Neurons | 19 | 2013 | 1546 | 1.330 |
Why?
|
| Poliomyelitis | 16 | 2011 | 28 | 1.320 |
Why?
|
| RNA, Viral | 22 | 2011 | 327 | 1.250 |
Why?
|
| Mice, Transgenic | 19 | 2019 | 1540 | 1.180 |
Why?
|
| Mutation | 27 | 2018 | 3968 | 1.160 |
Why?
|
| Mice | 69 | 2019 | 11352 | 1.130 |
Why?
|
| Multiple Sclerosis | 20 | 2020 | 262 | 1.130 |
Why?
|
| C9orf72 Protein | 3 | 2023 | 18 | 1.080 |
Why?
|
| Enterovirus | 16 | 2004 | 34 | 1.070 |
Why?
|
| Nucleotides | 2 | 2022 | 95 | 1.040 |
Why?
|
| Animals | 105 | 2021 | 26582 | 1.040 |
Why?
|
| DNA-Binding Proteins | 4 | 2020 | 1208 | 0.960 |
Why?
|
| Gene Knockdown Techniques | 4 | 2021 | 236 | 0.900 |
Why?
|
| Apoptosis | 11 | 2011 | 1683 | 0.860 |
Why?
|
| Polypyrimidine Tract-Binding Protein | 3 | 2020 | 14 | 0.860 |
Why?
|
| Protein Phosphatase 1 | 2 | 2019 | 34 | 0.840 |
Why?
|
| Oligodendroglia | 4 | 2020 | 123 | 0.820 |
Why?
|
| RNA-Binding Protein FUS | 2 | 2020 | 11 | 0.780 |
Why?
|
| Cell Death | 7 | 2018 | 256 | 0.780 |
Why?
|
| Dipeptides | 4 | 2023 | 46 | 0.770 |
Why?
|
| Active Transport, Cell Nucleus | 1 | 2020 | 75 | 0.730 |
Why?
|
| Animal Rights | 2 | 2016 | 2 | 0.700 |
Why?
|
| Animal Experimentation | 2 | 2016 | 7 | 0.700 |
Why?
|
| TDP-43 Proteinopathies | 1 | 2019 | 8 | 0.690 |
Why?
|
| Mice, Inbred C57BL | 13 | 2019 | 3092 | 0.690 |
Why?
|
| Stress, Physiological | 2 | 2020 | 227 | 0.680 |
Why?
|
| Enterovirus Infections | 12 | 1992 | 41 | 0.680 |
Why?
|
| Politics | 2 | 2016 | 50 | 0.670 |
Why?
|
| Single-Chain Antibodies | 1 | 2018 | 17 | 0.670 |
Why?
|
| Disease Models, Animal | 16 | 2018 | 2232 | 0.660 |
Why?
|
| Cricetinae | 22 | 2009 | 560 | 0.660 |
Why?
|
| Neurosciences | 2 | 2016 | 52 | 0.650 |
Why?
|
| Peripheral Nervous System Diseases | 3 | 2017 | 85 | 0.650 |
Why?
|
| Humans | 128 | 2023 | 86643 | 0.640 |
Why?
|
| Cell Line | 23 | 2019 | 2468 | 0.630 |
Why?
|
| Violence | 2 | 2016 | 143 | 0.590 |
Why?
|
| Zika Virus | 1 | 2016 | 14 | 0.590 |
Why?
|
| Zika Virus Infection | 1 | 2016 | 13 | 0.590 |
Why?
|
| Frontotemporal Dementia | 3 | 2023 | 27 | 0.580 |
Why?
|
| Capsid | 9 | 2000 | 34 | 0.550 |
Why?
|
| Kuru | 2 | 2015 | 3 | 0.540 |
Why?
|
| Codon, Initiator | 4 | 2023 | 21 | 0.540 |
Why?
|
| Schwann Cells | 2 | 2012 | 34 | 0.530 |
Why?
|
| Neuropathology | 1 | 2015 | 3 | 0.530 |
Why?
|
| Anthropology | 1 | 2015 | 8 | 0.530 |
Why?
|
| Creutzfeldt-Jakob Syndrome | 9 | 2001 | 25 | 0.530 |
Why?
|
| Hepatitis C | 1 | 2017 | 208 | 0.510 |
Why?
|
| Spinal Cord Diseases | 2 | 2013 | 29 | 0.510 |
Why?
|
| Guanabenz | 1 | 2014 | 4 | 0.510 |
Why?
|
| Protein Unfolding | 1 | 2014 | 12 | 0.510 |
Why?
|
| Poliovirus | 9 | 2004 | 23 | 0.500 |
Why?
|
| Biomedical Research | 2 | 2016 | 376 | 0.500 |
Why?
|
| Diaphragm | 1 | 2014 | 50 | 0.500 |
Why?
|
| Membrane Proteins | 7 | 2003 | 1196 | 0.490 |
Why?
|
| Respiration Disorders | 1 | 2014 | 39 | 0.490 |
Why?
|
| Motor Neuron Disease | 2 | 2013 | 21 | 0.480 |
Why?
|
| Prion Diseases | 4 | 2002 | 32 | 0.470 |
Why?
|
| Immunoglobulin Fragments | 1 | 2013 | 23 | 0.460 |
Why?
|
| Encephalitis | 7 | 2008 | 104 | 0.450 |
Why?
|
| Cells, Cultured | 12 | 2020 | 2818 | 0.440 |
Why?
|
| Antibodies, Viral | 14 | 2003 | 293 | 0.420 |
Why?
|
| Brain | 17 | 2008 | 2216 | 0.410 |
Why?
|
| Mutation, Missense | 2 | 2013 | 276 | 0.410 |
Why?
|
| Venous Thrombosis | 1 | 2014 | 243 | 0.410 |
Why?
|
| Base Sequence | 16 | 2011 | 2330 | 0.390 |
Why?
|
| Encephalopathy, Bovine Spongiform | 2 | 2001 | 2 | 0.390 |
Why?
|
| Virulence Factors | 1 | 2011 | 108 | 0.380 |
Why?
|
| Male | 49 | 2020 | 40965 | 0.380 |
Why?
|
| Unfolded Protein Response | 1 | 2010 | 39 | 0.380 |
Why?
|
| Polyneuropathies | 1 | 2011 | 27 | 0.380 |
Why?
|
| Interneurons | 2 | 2009 | 93 | 0.380 |
Why?
|
| Disease Progression | 3 | 2010 | 1531 | 0.380 |
Why?
|
| Glucose Intolerance | 1 | 2011 | 96 | 0.370 |
Why?
|
| Alzheimer Disease | 4 | 1999 | 470 | 0.370 |
Why?
|
| Immune Evasion | 1 | 2010 | 33 | 0.370 |
Why?
|
| Astrocytes | 2 | 2010 | 139 | 0.370 |
Why?
|
| Molecular Sequence Data | 18 | 2011 | 3030 | 0.370 |
Why?
|
| Hippocampus | 9 | 2009 | 442 | 0.370 |
Why?
|
| Gene Expression | 6 | 2009 | 1284 | 0.370 |
Why?
|
| Microglia | 2 | 2017 | 102 | 0.370 |
Why?
|
| Female | 48 | 2021 | 44532 | 0.360 |
Why?
|
| Interferon-beta | 1 | 2010 | 125 | 0.360 |
Why?
|
| Metabolic Syndrome | 1 | 2011 | 141 | 0.350 |
Why?
|
| Neuromuscular Junction | 3 | 1995 | 80 | 0.350 |
Why?
|
| Transfection | 13 | 2017 | 896 | 0.340 |
Why?
|
| Brain Stem | 2 | 2008 | 165 | 0.340 |
Why?
|
| Antigens, Viral | 14 | 2003 | 143 | 0.340 |
Why?
|
| Central Nervous System | 6 | 2010 | 151 | 0.330 |
Why?
|
| Prions | 3 | 2003 | 54 | 0.330 |
Why?
|
| Nervous System Diseases | 6 | 1996 | 151 | 0.330 |
Why?
|
| Pain | 2 | 2011 | 391 | 0.320 |
Why?
|
| Genes, Viral | 9 | 2000 | 116 | 0.320 |
Why?
|
| Gene Expression Regulation, Enzymologic | 2 | 2007 | 214 | 0.320 |
Why?
|
| Macrophages | 4 | 2009 | 554 | 0.320 |
Why?
|
| Middle Aged | 42 | 2021 | 25028 | 0.310 |
Why?
|
| Codon | 3 | 2022 | 124 | 0.310 |
Why?
|
| DNA, Viral | 11 | 1996 | 265 | 0.310 |
Why?
|
| Postpoliomyelitis Syndrome | 4 | 1995 | 6 | 0.300 |
Why?
|
| Neoplasms | 1 | 2022 | 2898 | 0.300 |
Why?
|
| Depression | 1 | 2011 | 473 | 0.300 |
Why?
|
| Protein Processing, Post-Translational | 5 | 2017 | 371 | 0.290 |
Why?
|
| Trans-Activators | 2 | 1999 | 429 | 0.290 |
Why?
|
| Enzyme Inhibitors | 5 | 2009 | 639 | 0.290 |
Why?
|
| Chick Embryo | 3 | 2018 | 229 | 0.290 |
Why?
|
| Virus Replication | 6 | 1999 | 319 | 0.280 |
Why?
|
| Cardiovirus Infections | 3 | 2003 | 28 | 0.280 |
Why?
|
| Adenoviridae | 9 | 2003 | 345 | 0.270 |
Why?
|
| Immunoglobulin G | 17 | 1996 | 456 | 0.270 |
Why?
|
| HEK293 Cells | 5 | 2021 | 615 | 0.270 |
Why?
|
| PC12 Cells | 6 | 2002 | 115 | 0.270 |
Why?
|
| Nerve Degeneration | 3 | 2021 | 83 | 0.260 |
Why?
|
| Picornaviridae | 4 | 1997 | 8 | 0.260 |
Why?
|
| Protein Sorting Signals | 2 | 1995 | 43 | 0.260 |
Why?
|
| Viruses | 3 | 2001 | 78 | 0.260 |
Why?
|
| Poliovirus Vaccine, Oral | 1 | 2004 | 4 | 0.260 |
Why?
|
| Genetic Vectors | 6 | 1999 | 439 | 0.250 |
Why?
|
| Penetrance | 2 | 2003 | 44 | 0.250 |
Why?
|
| Age of Onset | 3 | 2003 | 310 | 0.240 |
Why?
|
| Cloning, Molecular | 5 | 2013 | 646 | 0.240 |
Why?
|
| Synaptic Transmission | 4 | 1996 | 222 | 0.240 |
Why?
|
| CD4-Positive T-Lymphocytes | 2 | 2004 | 425 | 0.240 |
Why?
|
| Endoplasmic Reticulum Stress | 2 | 2015 | 83 | 0.240 |
Why?
|
| Sclerosis | 1 | 2003 | 28 | 0.240 |
Why?
|
| Pick Disease of the Brain | 1 | 2023 | 6 | 0.240 |
Why?
|
| 5' Untranslated Regions | 2 | 2022 | 49 | 0.230 |
Why?
|
| Carboxypeptidases | 1 | 2003 | 35 | 0.230 |
Why?
|
| Lymphotoxin-alpha | 1 | 2003 | 44 | 0.230 |
Why?
|
| Receptors, Tumor Necrosis Factor | 1 | 2003 | 88 | 0.230 |
Why?
|
| Rats | 14 | 2009 | 3990 | 0.230 |
Why?
|
| Virulence | 9 | 2004 | 271 | 0.230 |
Why?
|
| DNA Primers | 5 | 2011 | 543 | 0.230 |
Why?
|
| Cytoplasm | 2 | 2019 | 281 | 0.220 |
Why?
|
| Virus Diseases | 6 | 1989 | 97 | 0.220 |
Why?
|
| Peptide Chain Initiation, Translational | 1 | 2022 | 18 | 0.220 |
Why?
|
| Equipment Contamination | 1 | 2002 | 22 | 0.220 |
Why?
|
| RNA Viruses | 3 | 1995 | 9 | 0.220 |
Why?
|
| Blotting, Western | 5 | 2013 | 782 | 0.220 |
Why?
|
| Amino Acid Sequence | 8 | 2011 | 2062 | 0.220 |
Why?
|
| Huntington Disease | 4 | 2016 | 37 | 0.220 |
Why?
|
| Surgical Instruments | 1 | 2002 | 57 | 0.210 |
Why?
|
| Iatrogenic Disease | 1 | 2002 | 69 | 0.210 |
Why?
|
| Epilepsy, Temporal Lobe | 1 | 2003 | 122 | 0.210 |
Why?
|
| HIV-1 | 3 | 2002 | 163 | 0.210 |
Why?
|
| Neurodegenerative Diseases | 2 | 2017 | 44 | 0.210 |
Why?
|
| Human T-lymphotropic virus 1 | 3 | 1997 | 14 | 0.210 |
Why?
|
| Cytokines | 2 | 2014 | 776 | 0.210 |
Why?
|
| Ribonucleoproteins | 1 | 2001 | 38 | 0.210 |
Why?
|
| Immunohistochemistry | 5 | 2009 | 1753 | 0.200 |
Why?
|
| Cytoskeletal Proteins | 2 | 1999 | 223 | 0.200 |
Why?
|
| Survival Analysis | 3 | 2016 | 1538 | 0.200 |
Why?
|
| Communicable Disease Control | 1 | 2001 | 51 | 0.200 |
Why?
|
| HeLa Cells | 4 | 2017 | 498 | 0.190 |
Why?
|
| Animals, Newborn | 2 | 2019 | 510 | 0.190 |
Why?
|
| Disease Transmission, Infectious | 1 | 2001 | 57 | 0.190 |
Why?
|
| Motor Cortex | 3 | 2017 | 195 | 0.190 |
Why?
|
| Neurosurgical Procedures | 1 | 2002 | 213 | 0.180 |
Why?
|
| Serpins | 1 | 2000 | 29 | 0.180 |
Why?
|
| Serine Proteinase Inhibitors | 1 | 2000 | 28 | 0.180 |
Why?
|
| Neuromuscular Diseases | 2 | 1990 | 30 | 0.180 |
Why?
|
| Gene Expression Regulation, Viral | 2 | 1997 | 90 | 0.180 |
Why?
|
| Machine Learning | 1 | 2022 | 232 | 0.180 |
Why?
|
| Receptor, trkA | 1 | 1999 | 14 | 0.180 |
Why?
|
| Neuropeptides | 1 | 2000 | 112 | 0.180 |
Why?
|
| RNA-Binding Proteins | 1 | 2001 | 246 | 0.180 |
Why?
|
| Caenorhabditis elegans | 1 | 2021 | 223 | 0.180 |
Why?
|
| Neutralization Tests | 10 | 2000 | 77 | 0.180 |
Why?
|
| Gliosis | 2 | 2018 | 35 | 0.180 |
Why?
|
| Immunophilins | 1 | 1999 | 5 | 0.180 |
Why?
|
| Autopsy | 2 | 2019 | 116 | 0.170 |
Why?
|
| Adult | 36 | 2020 | 25648 | 0.170 |
Why?
|
| Calcineurin | 1 | 1999 | 16 | 0.170 |
Why?
|
| Mice, Knockout | 4 | 2018 | 1924 | 0.170 |
Why?
|
| Protein Precursors | 2 | 2000 | 143 | 0.170 |
Why?
|
| RNA, Messenger | 4 | 2010 | 1981 | 0.170 |
Why?
|
| Glycoproteins | 2 | 2000 | 234 | 0.170 |
Why?
|
| Protein Aggregation, Pathological | 1 | 2018 | 7 | 0.170 |
Why?
|
| Kidney | 8 | 2008 | 1241 | 0.170 |
Why?
|
| Calcium-Binding Proteins | 2 | 2014 | 115 | 0.170 |
Why?
|
| Cadherins | 1 | 1999 | 151 | 0.170 |
Why?
|
| Mitogen-Activated Protein Kinases | 1 | 1999 | 222 | 0.160 |
Why?
|
| Mice, Inbred Strains | 11 | 2000 | 307 | 0.160 |
Why?
|
| Poloxamer | 1 | 2018 | 29 | 0.160 |
Why?
|
| Sural Nerve | 2 | 2017 | 19 | 0.160 |
Why?
|
| Enzyme-Linked Immunosorbent Assay | 2 | 2013 | 376 | 0.160 |
Why?
|
| Zebrafish Proteins | 1 | 1999 | 144 | 0.160 |
Why?
|
| Aged | 25 | 2017 | 18415 | 0.160 |
Why?
|
| Cryoglobulinemia | 1 | 2017 | 6 | 0.160 |
Why?
|
| Poly(A)-Binding Proteins | 1 | 2017 | 9 | 0.150 |
Why?
|
| Sciatic Nerve | 2 | 2008 | 33 | 0.150 |
Why?
|
| Down-Regulation | 1 | 1999 | 504 | 0.150 |
Why?
|
| Vasculitis | 1 | 2017 | 39 | 0.150 |
Why?
|
| Diagnosis, Differential | 4 | 2013 | 1565 | 0.150 |
Why?
|
| Cell Membrane | 3 | 2018 | 666 | 0.150 |
Why?
|
| Protein Transport | 1 | 2019 | 411 | 0.150 |
Why?
|
| HIV Envelope Protein gp120 | 3 | 2009 | 19 | 0.150 |
Why?
|
| HTLV-I Infections | 3 | 1994 | 7 | 0.150 |
Why?
|
| Epitopes, B-Lymphocyte | 1 | 1996 | 5 | 0.150 |
Why?
|
| Glutamate Carboxypeptidase II | 2 | 2009 | 8 | 0.150 |
Why?
|
| Spastic Paraplegia, Hereditary | 2 | 2000 | 8 | 0.150 |
Why?
|
| Binding Sites | 4 | 2004 | 1098 | 0.150 |
Why?
|
| Luminescent Proteins | 3 | 2013 | 144 | 0.140 |
Why?
|
| Cell Nucleus | 1 | 2019 | 579 | 0.140 |
Why?
|
| Family Health | 4 | 2017 | 162 | 0.140 |
Why?
|
| Prodromal Symptoms | 1 | 2016 | 2 | 0.140 |
Why?
|
| Vital Capacity | 1 | 2016 | 64 | 0.140 |
Why?
|
| Molecular Chaperones | 1 | 2017 | 111 | 0.140 |
Why?
|
| Dendrites | 1 | 2017 | 99 | 0.140 |
Why?
|
| Enteral Nutrition | 1 | 2016 | 102 | 0.140 |
Why?
|
| Gastrostomy | 1 | 2016 | 69 | 0.140 |
Why?
|
| Glycine | 2 | 2021 | 92 | 0.140 |
Why?
|
| Emergencies | 1 | 2016 | 113 | 0.140 |
Why?
|
| Aged, 80 and over | 6 | 2017 | 6509 | 0.140 |
Why?
|
| Carrier Proteins | 2 | 1999 | 673 | 0.140 |
Why?
|
| Arginine | 2 | 2021 | 136 | 0.140 |
Why?
|
| Subacute Sclerosing Panencephalitis | 9 | 1986 | 16 | 0.140 |
Why?
|
| Time Factors | 10 | 2017 | 5210 | 0.140 |
Why?
|
| Polyradiculopathy | 1 | 2015 | 6 | 0.140 |
Why?
|
| Cauda Equina | 1 | 2015 | 13 | 0.140 |
Why?
|
| Protein Multimerization | 1 | 2017 | 173 | 0.130 |
Why?
|
| Postoperative Complications | 2 | 2016 | 2207 | 0.130 |
Why?
|
| Cell Survival | 4 | 2003 | 969 | 0.130 |
Why?
|
| Public Health | 1 | 2016 | 129 | 0.130 |
Why?
|
| Alanine | 3 | 2021 | 85 | 0.130 |
Why?
|
| Transcription, Genetic | 8 | 1997 | 1135 | 0.130 |
Why?
|
| Rectal Fistula | 1 | 2015 | 18 | 0.130 |
Why?
|
| Meningitis, Viral | 3 | 1992 | 10 | 0.130 |
Why?
|
| DNA Viruses | 1 | 1995 | 16 | 0.130 |
Why?
|
| Electroporation | 2 | 2005 | 55 | 0.130 |
Why?
|
| Presenilin-1 | 3 | 1999 | 100 | 0.130 |
Why?
|
| Fecal Incontinence | 1 | 2015 | 57 | 0.130 |
Why?
|
| Cerebral Cortex | 2 | 2016 | 584 | 0.130 |
Why?
|
| Space Perception | 1 | 2016 | 115 | 0.130 |
Why?
|
| Capsid Proteins | 6 | 2004 | 32 | 0.130 |
Why?
|
| Autoimmune Diseases | 2 | 1995 | 241 | 0.130 |
Why?
|
| Recombination, Genetic | 5 | 2008 | 439 | 0.130 |
Why?
|
| Ubiquitin Thiolesterase | 1 | 2015 | 63 | 0.130 |
Why?
|
| Glial Fibrillary Acidic Protein | 1 | 2014 | 58 | 0.130 |
Why?
|
| Neuroimaging | 1 | 2015 | 113 | 0.130 |
Why?
|
| Muscle, Skeletal | 2 | 2017 | 449 | 0.120 |
Why?
|
| Anal Canal | 1 | 2015 | 89 | 0.120 |
Why?
|
| DNA | 7 | 2001 | 1294 | 0.120 |
Why?
|
| Algorithms | 1 | 2022 | 1830 | 0.120 |
Why?
|
| History, 21st Century | 1 | 2015 | 175 | 0.120 |
Why?
|
| Eukaryotic Initiation Factor-2 | 1 | 2013 | 15 | 0.120 |
Why?
|
| Spinal Muscular Atrophies of Childhood | 1 | 1993 | 4 | 0.120 |
Why?
|
| Plasmids | 5 | 2001 | 287 | 0.120 |
Why?
|
| Recombinant Fusion Proteins | 5 | 2002 | 557 | 0.120 |
Why?
|
| Genome, Viral | 4 | 1998 | 74 | 0.120 |
Why?
|
| Immunity, Innate | 1 | 2017 | 409 | 0.120 |
Why?
|
| Pyramidal Cells | 4 | 2017 | 80 | 0.120 |
Why?
|
| History, 20th Century | 1 | 2015 | 312 | 0.120 |
Why?
|
| Age Factors | 3 | 2015 | 1851 | 0.120 |
Why?
|
| Bacteriophage M13 | 1 | 2013 | 9 | 0.120 |
Why?
|
| Family | 4 | 2009 | 311 | 0.120 |
Why?
|
| MAP Kinase Kinase Kinases | 2 | 2004 | 41 | 0.120 |
Why?
|
| Amino Acid Substitution | 3 | 2003 | 339 | 0.110 |
Why?
|
| Neuronal Plasticity | 1 | 2015 | 187 | 0.110 |
Why?
|
| Biotinylation | 1 | 2013 | 41 | 0.110 |
Why?
|
| Microfilament Proteins | 1 | 2014 | 208 | 0.110 |
Why?
|
| Encephalitis, Arbovirus | 1 | 1992 | 3 | 0.110 |
Why?
|
| Visual Perception | 1 | 2016 | 319 | 0.110 |
Why?
|
| Gene Expression Regulation | 4 | 2015 | 1920 | 0.110 |
Why?
|
| Ribosomes | 2 | 2004 | 111 | 0.110 |
Why?
|
| Green Fluorescent Proteins | 2 | 2017 | 305 | 0.110 |
Why?
|
| Isoelectric Focusing | 12 | 1991 | 39 | 0.110 |
Why?
|
| Syndrome | 4 | 2008 | 446 | 0.110 |
Why?
|
| Antibodies, Monoclonal | 5 | 1996 | 1376 | 0.100 |
Why?
|
| Pedigree | 7 | 2003 | 966 | 0.100 |
Why?
|
| Rodent Diseases | 1 | 2011 | 34 | 0.100 |
Why?
|
| Hypothalamic Area, Lateral | 1 | 1991 | 11 | 0.100 |
Why?
|
| Electromyography | 5 | 2017 | 183 | 0.100 |
Why?
|
| Introns | 1 | 1992 | 289 | 0.100 |
Why?
|
| Excitatory Amino Acid Transporter 2 | 1 | 2010 | 2 | 0.100 |
Why?
|
| Immunoglobulins | 4 | 1988 | 148 | 0.100 |
Why?
|
| Hereditary Sensory and Motor Neuropathy | 1 | 1990 | 2 | 0.100 |
Why?
|
| eIF-2 Kinase | 1 | 2010 | 46 | 0.100 |
Why?
|
| G(M1) Ganglioside | 1 | 1990 | 3 | 0.090 |
Why?
|
| Immunoglobulin mu-Chains | 1 | 1990 | 18 | 0.090 |
Why?
|
| Sequence Homology, Amino Acid | 1 | 2011 | 416 | 0.090 |
Why?
|
| Retroviridae | 3 | 1999 | 79 | 0.090 |
Why?
|
| T-Lymphocytes, Cytotoxic | 3 | 2003 | 315 | 0.090 |
Why?
|
| Central Nervous System Diseases | 3 | 1994 | 52 | 0.090 |
Why?
|
| Brain Diseases | 3 | 1999 | 180 | 0.090 |
Why?
|
| Muscles | 5 | 1995 | 194 | 0.090 |
Why?
|
| Nitric Oxide Synthase | 2 | 2000 | 125 | 0.090 |
Why?
|
| Estrogen Antagonists | 1 | 2010 | 48 | 0.090 |
Why?
|
| Ion Channel Gating | 2 | 2011 | 324 | 0.090 |
Why?
|
| Cattle | 2 | 2001 | 376 | 0.090 |
Why?
|
| Gene Transfer Techniques | 2 | 2000 | 152 | 0.090 |
Why?
|
| AIDS Dementia Complex | 1 | 2009 | 8 | 0.090 |
Why?
|
| Child | 4 | 2020 | 6927 | 0.090 |
Why?
|
| Protein Conformation | 3 | 2011 | 881 | 0.090 |
Why?
|
| Organophosphorus Compounds | 1 | 2009 | 55 | 0.090 |
Why?
|
| Endoplasmic Reticulum | 1 | 2010 | 250 | 0.090 |
Why?
|
| Tamoxifen | 1 | 2010 | 168 | 0.080 |
Why?
|
| Dimerization | 1 | 2009 | 143 | 0.080 |
Why?
|
| Autoantibodies | 1 | 1990 | 267 | 0.080 |
Why?
|
| Acquired Immunodeficiency Syndrome | 4 | 1991 | 78 | 0.080 |
Why?
|
| Methylprednisolone Hemisuccinate | 1 | 2008 | 10 | 0.080 |
Why?
|
| Valine | 2 | 2011 | 69 | 0.080 |
Why?
|
| Protein Folding | 2 | 2005 | 282 | 0.080 |
Why?
|
| Trazodone | 1 | 1988 | 1 | 0.080 |
Why?
|
| Epitopes | 6 | 1991 | 255 | 0.080 |
Why?
|
| Olivopontocerebellar Atrophies | 1 | 1988 | 6 | 0.080 |
Why?
|
| Spinocerebellar Degenerations | 1 | 1988 | 18 | 0.080 |
Why?
|
| Nerve Tissue Proteins | 5 | 2015 | 503 | 0.080 |
Why?
|
| Measles virus | 4 | 1988 | 14 | 0.080 |
Why?
|
| Gerstmann-Straussler-Scheinker Disease | 2 | 2000 | 13 | 0.080 |
Why?
|
| Quality of Life | 2 | 2015 | 1585 | 0.080 |
Why?
|
| beta Catenin | 2 | 1999 | 251 | 0.080 |
Why?
|
| Free Radicals | 3 | 1997 | 73 | 0.080 |
Why?
|
| Prednisone | 1 | 2008 | 258 | 0.080 |
Why?
|
| Exons | 2 | 2003 | 450 | 0.080 |
Why?
|
| Amyloid | 2 | 2000 | 85 | 0.080 |
Why?
|
| Nerve Growth Factors | 2 | 1999 | 63 | 0.080 |
Why?
|
| Recombinant Proteins | 4 | 1997 | 1014 | 0.080 |
Why?
|
| Biomarkers | 1 | 2013 | 1718 | 0.080 |
Why?
|
| Oxidative Stress | 2 | 2002 | 447 | 0.080 |
Why?
|
| Neuroglia | 4 | 2009 | 104 | 0.070 |
Why?
|
| Sleep Apnea Syndromes | 1 | 1988 | 103 | 0.070 |
Why?
|
| Reverse Transcriptase Polymerase Chain Reaction | 3 | 2004 | 879 | 0.070 |
Why?
|
| Peripheral Nervous System Neoplasms | 1 | 1986 | 19 | 0.070 |
Why?
|
| DNA Mutational Analysis | 2 | 2003 | 526 | 0.070 |
Why?
|
| Measles | 2 | 1988 | 15 | 0.070 |
Why?
|
| Picornaviridae Infections | 2 | 1985 | 7 | 0.070 |
Why?
|
| Gene Expression Regulation, Developmental | 1 | 2010 | 623 | 0.070 |
Why?
|
| Trypsin | 3 | 1995 | 95 | 0.070 |
Why?
|
| Endometriosis | 1 | 1986 | 58 | 0.070 |
Why?
|
| Mutagenesis, Site-Directed | 3 | 1996 | 279 | 0.070 |
Why?
|
| Protein Binding | 3 | 2017 | 1456 | 0.070 |
Why?
|
| Immunosuppressive Agents | 2 | 1999 | 977 | 0.070 |
Why?
|
| Phenotype | 5 | 2000 | 2378 | 0.070 |
Why?
|
| Enzyme Activation | 3 | 2004 | 692 | 0.060 |
Why?
|
| Chickens | 1 | 2005 | 212 | 0.060 |
Why?
|
| Signal Transduction | 2 | 2010 | 3241 | 0.060 |
Why?
|
| DNA, Recombinant | 3 | 1995 | 67 | 0.060 |
Why?
|
| Motor Endplate | 2 | 1995 | 31 | 0.060 |
Why?
|
| Encephalomyelitis, Autoimmune, Experimental | 3 | 1997 | 57 | 0.060 |
Why?
|
| 1-Methyl-4-phenylpyridinium | 1 | 2004 | 12 | 0.060 |
Why?
|
| Membrane Potentials | 3 | 2011 | 435 | 0.060 |
Why?
|
| Mice, Inbred DBA | 2 | 1997 | 148 | 0.060 |
Why?
|
| Biopsy | 6 | 1995 | 1163 | 0.060 |
Why?
|
| Adoptive Transfer | 1 | 2004 | 168 | 0.060 |
Why?
|
| Advance Directives | 2 | 1996 | 64 | 0.060 |
Why?
|
| Respirovirus Infections | 2 | 1985 | 12 | 0.060 |
Why?
|
| Lymphotoxin-beta | 1 | 2003 | 7 | 0.060 |
Why?
|
| Depressive Disorder | 1 | 1985 | 218 | 0.060 |
Why?
|
| Receptors, Tumor Necrosis Factor, Type II | 1 | 2003 | 20 | 0.060 |
Why?
|
| Lymphotoxin beta Receptor | 1 | 2003 | 29 | 0.060 |
Why?
|
| Home Care Services | 2 | 1996 | 72 | 0.060 |
Why?
|
| Disease Susceptibility | 1 | 2004 | 193 | 0.060 |
Why?
|
| Receptors, Tumor Necrosis Factor, Type I | 1 | 2003 | 43 | 0.060 |
Why?
|
| Mutagenesis | 2 | 1995 | 199 | 0.060 |
Why?
|
| Evoked Potentials | 2 | 1995 | 190 | 0.060 |
Why?
|
| Transforming Growth Factor beta | 3 | 2009 | 301 | 0.060 |
Why?
|
| Adolescent | 10 | 2015 | 8981 | 0.060 |
Why?
|
| CD8-Positive T-Lymphocytes | 2 | 2004 | 559 | 0.060 |
Why?
|
| Cytotoxicity, Immunologic | 3 | 2000 | 213 | 0.060 |
Why?
|
| Nerve Growth Factor | 1 | 2002 | 17 | 0.060 |
Why?
|
| Glutamic Acid | 1 | 2003 | 152 | 0.060 |
Why?
|
| Cathepsin B | 1 | 2002 | 12 | 0.060 |
Why?
|
| Multienzyme Complexes | 1 | 2002 | 64 | 0.050 |
Why?
|
| Killer Cells, Natural | 2 | 2003 | 267 | 0.050 |
Why?
|
| HTLV-I Antibodies | 3 | 1994 | 3 | 0.050 |
Why?
|
| Cysteine Endopeptidases | 1 | 2002 | 87 | 0.050 |
Why?
|
| Macromolecular Substances | 1 | 2002 | 177 | 0.050 |
Why?
|
| Oxidants | 1 | 2002 | 86 | 0.050 |
Why?
|
| Protein Structure, Tertiary | 2 | 1995 | 736 | 0.050 |
Why?
|
| Chimera | 2 | 1993 | 56 | 0.050 |
Why?
|
| Proteasome Endopeptidase Complex | 1 | 2002 | 100 | 0.050 |
Why?
|
| Neuroblastoma | 2 | 2011 | 374 | 0.050 |
Why?
|
| Transduction, Genetic | 1 | 2002 | 153 | 0.050 |
Why?
|
| Inclusion Bodies, Viral | 1 | 1981 | 9 | 0.050 |
Why?
|
| Respiration, Artificial | 2 | 1996 | 334 | 0.050 |
Why?
|
| Hydrogen Peroxide | 1 | 2002 | 158 | 0.050 |
Why?
|
| S100 Calcium Binding Protein G | 3 | 1997 | 22 | 0.050 |
Why?
|
| Abattoirs | 1 | 2001 | 2 | 0.050 |
Why?
|
| Polymorphism, Genetic | 2 | 2003 | 819 | 0.050 |
Why?
|
| Proline | 1 | 2021 | 57 | 0.050 |
Why?
|
| Antigens, CD | 1 | 2003 | 458 | 0.050 |
Why?
|
| Transfusion Reaction | 1 | 2001 | 15 | 0.050 |
Why?
|
| Calcium | 3 | 2011 | 1156 | 0.050 |
Why?
|
| Gene Editing | 1 | 2021 | 42 | 0.050 |
Why?
|
| Mice, SCID | 3 | 1996 | 252 | 0.050 |
Why?
|
| Staining and Labeling | 5 | 1992 | 165 | 0.050 |
Why?
|
| Schizophrenia | 1 | 1985 | 464 | 0.050 |
Why?
|
| Immunoglobulin gamma-Chains | 3 | 1989 | 14 | 0.050 |
Why?
|
| Mastadenovirus | 1 | 2000 | 4 | 0.050 |
Why?
|
| Immunoglobulin Heavy Chains | 4 | 1989 | 131 | 0.050 |
Why?
|
| Lac Operon | 1 | 2000 | 46 | 0.050 |
Why?
|
| B-Lymphocytes | 2 | 1985 | 724 | 0.050 |
Why?
|
| Action Potentials | 2 | 1995 | 573 | 0.050 |
Why?
|
| Tumor Cells, Cultured | 2 | 1999 | 1041 | 0.050 |
Why?
|
| Prion Proteins | 1 | 2000 | 10 | 0.050 |
Why?
|
| Inclusion Bodies | 1 | 2000 | 34 | 0.050 |
Why?
|
| Vasospasm, Intracranial | 1 | 2000 | 36 | 0.050 |
Why?
|
| Cell Line, Tumor | 3 | 2013 | 2426 | 0.050 |
Why?
|
| Restriction Mapping | 2 | 1989 | 157 | 0.040 |
Why?
|
| Glycogen Synthase Kinases | 1 | 1999 | 4 | 0.040 |
Why?
|
| Mice, Inbred BALB C | 2 | 1997 | 1047 | 0.040 |
Why?
|
| Tumor Necrosis Factor-alpha | 1 | 2003 | 683 | 0.040 |
Why?
|
| Ribosomal Protein S6 Kinases | 1 | 1999 | 10 | 0.040 |
Why?
|
| Point Mutation | 1 | 2000 | 246 | 0.040 |
Why?
|
| Viral Structural Proteins | 2 | 1990 | 19 | 0.040 |
Why?
|
| Peptide Fragments | 2 | 1996 | 460 | 0.040 |
Why?
|
| RNA | 2 | 2001 | 560 | 0.040 |
Why?
|
| Dose-Response Relationship, Drug | 4 | 2009 | 1961 | 0.040 |
Why?
|
| Neurotoxins | 2 | 1997 | 49 | 0.040 |
Why?
|
| Genetic Counseling | 1 | 2000 | 100 | 0.040 |
Why?
|
| Calcium-Calmodulin-Dependent Protein Kinases | 1 | 1999 | 85 | 0.040 |
Why?
|
| Subarachnoid Hemorrhage | 1 | 2000 | 137 | 0.040 |
Why?
|
| Bacterial Proteins | 1 | 2005 | 864 | 0.040 |
Why?
|
| Antioxidants | 2 | 1997 | 223 | 0.040 |
Why?
|
| Glycogen Synthase Kinase 3 | 1 | 1999 | 63 | 0.040 |
Why?
|
| Paramyxoviridae | 1 | 1979 | 10 | 0.040 |
Why?
|
| H-2 Antigens | 1 | 1999 | 58 | 0.040 |
Why?
|
| JNK Mitogen-Activated Protein Kinases | 1 | 1999 | 113 | 0.040 |
Why?
|
| Frontal Lobe | 1 | 1999 | 130 | 0.040 |
Why?
|
| Wnt Proteins | 1 | 1999 | 123 | 0.040 |
Why?
|
| Herpes Simplex | 3 | 1988 | 202 | 0.040 |
Why?
|
| Genetic Techniques | 2 | 1996 | 72 | 0.040 |
Why?
|
| Phosphatidylinositol 3-Kinases | 1 | 1999 | 262 | 0.040 |
Why?
|
| Alleles | 1 | 2001 | 1128 | 0.040 |
Why?
|
| Surface-Active Agents | 1 | 2018 | 59 | 0.040 |
Why?
|
| Proteins | 1 | 2023 | 777 | 0.040 |
Why?
|
| Immunoglobulin M | 2 | 1992 | 154 | 0.040 |
Why?
|
| Withholding Treatment | 2 | 1996 | 112 | 0.040 |
Why?
|
| T-Cell Intracellular Antigen-1 | 1 | 2017 | 6 | 0.040 |
Why?
|
| Afferent Pathways | 2 | 2015 | 77 | 0.040 |
Why?
|
| Heterogeneous-Nuclear Ribonucleoprotein Group A-B | 1 | 2017 | 3 | 0.040 |
Why?
|
| Heterogeneous Nuclear Ribonucleoprotein A1 | 1 | 2017 | 2 | 0.040 |
Why?
|
| Immune System | 1 | 1998 | 93 | 0.040 |
Why?
|
| Proto-Oncogene Proteins c-akt | 1 | 1999 | 322 | 0.040 |
Why?
|
| Superoxides | 1 | 1997 | 73 | 0.040 |
Why?
|
| Genes, pX | 1 | 1997 | 1 | 0.040 |
Why?
|
| Gene Products, tax | 1 | 1997 | 4 | 0.040 |
Why?
|
| Enterovirus B, Human | 1 | 1997 | 10 | 0.040 |
Why?
|
| Chelating Agents | 1 | 1997 | 69 | 0.040 |
Why?
|
| Alternative Splicing | 1 | 1999 | 201 | 0.040 |
Why?
|
| Staurosporine | 1 | 1997 | 33 | 0.040 |
Why?
|
| Neurocognitive Disorders | 1 | 1977 | 13 | 0.040 |
Why?
|
| Aphthovirus | 1 | 1996 | 1 | 0.040 |
Why?
|
| Reactive Oxygen Species | 2 | 1997 | 480 | 0.040 |
Why?
|
| Tuberous Sclerosis | 1 | 1977 | 28 | 0.040 |
Why?
|
| Visual Analog Scale | 1 | 2016 | 14 | 0.040 |
Why?
|
| Acylation | 1 | 2017 | 38 | 0.040 |
Why?
|
| Immunoenzyme Techniques | 4 | 1987 | 303 | 0.040 |
Why?
|
| Repetitive Sequences, Nucleic Acid | 1 | 1997 | 135 | 0.040 |
Why?
|
| Myositis | 1 | 1996 | 17 | 0.040 |
Why?
|
| Protein Stability | 1 | 2017 | 99 | 0.040 |
Why?
|
| Deltaretrovirus Infections | 1 | 1996 | 1 | 0.040 |
Why?
|
| Microscopy, Confocal | 1 | 2017 | 268 | 0.040 |
Why?
|
| Arm | 1 | 2017 | 91 | 0.040 |
Why?
|
| Endopeptidases | 1 | 1996 | 116 | 0.040 |
Why?
|
| Myocarditis | 1 | 1996 | 50 | 0.040 |
Why?
|
| Antibody Specificity | 5 | 1988 | 129 | 0.040 |
Why?
|
| Magnetic Resonance Imaging | 1 | 2008 | 3362 | 0.030 |
Why?
|
| Advance Care Planning | 1 | 1996 | 43 | 0.030 |
Why?
|
| Neuroprotective Agents | 2 | 2009 | 94 | 0.030 |
Why?
|
| Proto-Oncogene Proteins | 1 | 1999 | 645 | 0.030 |
Why?
|
| Molecular Biology | 1 | 1996 | 89 | 0.030 |
Why?
|
| Cholinesterases | 1 | 1995 | 17 | 0.030 |
Why?
|
| Glioma | 1 | 1998 | 285 | 0.030 |
Why?
|
| Microscopy, Fluorescence | 1 | 2017 | 425 | 0.030 |
Why?
|
| Defective Viruses | 1 | 1995 | 12 | 0.030 |
Why?
|
| Zinc | 1 | 1995 | 91 | 0.030 |
Why?
|
| Open Reading Frames | 1 | 1995 | 117 | 0.030 |
Why?
|
| Tibial Nerve | 1 | 1995 | 14 | 0.030 |
Why?
|
| Axonal Transport | 1 | 1995 | 31 | 0.030 |
Why?
|
| Crystallography, X-Ray | 1 | 1996 | 485 | 0.030 |
Why?
|
| Hypoglossal Nerve | 1 | 1995 | 26 | 0.030 |
Why?
|
| Phenylalanine | 1 | 1995 | 37 | 0.030 |
Why?
|
| Sequence Deletion | 1 | 1995 | 205 | 0.030 |
Why?
|
| Conserved Sequence | 1 | 1995 | 210 | 0.030 |
Why?
|
| Muscle Strength | 1 | 2015 | 31 | 0.030 |
Why?
|
| Chromosome Mapping | 3 | 1995 | 1074 | 0.030 |
Why?
|
| Myelin Sheath | 3 | 1984 | 84 | 0.030 |
Why?
|
| Polymorphism, Single Nucleotide | 1 | 2003 | 2357 | 0.030 |
Why?
|
| Cerebral Ventricles | 1 | 1995 | 76 | 0.030 |
Why?
|
| Sympathetic Nervous System | 1 | 1995 | 104 | 0.030 |
Why?
|
| Genetic Predisposition to Disease | 1 | 2003 | 2271 | 0.030 |
Why?
|
| Myelin Basic Protein | 3 | 1983 | 49 | 0.030 |
Why?
|
| Visna-maedi virus | 2 | 1985 | 3 | 0.030 |
Why?
|
| Treatment Outcome | 3 | 2016 | 7993 | 0.030 |
Why?
|
| Electric Stimulation | 2 | 2011 | 347 | 0.030 |
Why?
|
| Genetic Engineering | 2 | 1996 | 114 | 0.030 |
Why?
|
| Tumor Suppressor Protein p53 | 1 | 1997 | 381 | 0.030 |
Why?
|
| Amyloid beta-Peptides | 1 | 1996 | 203 | 0.030 |
Why?
|
| Muscular Atrophy | 2 | 1987 | 41 | 0.030 |
Why?
|
| Lysine | 1 | 1995 | 147 | 0.030 |
Why?
|
| Myofibrils | 1 | 1993 | 23 | 0.030 |
Why?
|
| Digestive System Surgical Procedures | 1 | 2015 | 120 | 0.030 |
Why?
|
| Lymphocytes | 3 | 1980 | 464 | 0.030 |
Why?
|
| Microelectrodes | 1 | 1993 | 81 | 0.030 |
Why?
|
| Paraparesis, Tropical Spastic | 2 | 1994 | 2 | 0.030 |
Why?
|
| Acetylcholine | 1 | 1993 | 176 | 0.030 |
Why?
|
| Lipoylation | 1 | 2013 | 28 | 0.030 |
Why?
|
| Immunoglobulin lambda-Chains | 2 | 1991 | 42 | 0.030 |
Why?
|
| Polymerase Chain Reaction | 4 | 1996 | 927 | 0.030 |
Why?
|
| Carbazoles | 2 | 2004 | 51 | 0.030 |
Why?
|
| X-Ray Diffraction | 1 | 1993 | 124 | 0.030 |
Why?
|
| Disulfides | 1 | 2013 | 64 | 0.030 |
Why?
|
| Longitudinal Studies | 1 | 2016 | 1019 | 0.030 |
Why?
|
| Antibody Formation | 3 | 1987 | 171 | 0.030 |
Why?
|
| Neurotransmitter Agents | 1 | 1993 | 106 | 0.030 |
Why?
|
| Magnesium | 1 | 1993 | 177 | 0.030 |
Why?
|
| Immunoglobulin kappa-Chains | 2 | 1991 | 96 | 0.030 |
Why?
|
| Genetic Linkage | 2 | 1989 | 623 | 0.030 |
Why?
|
| Synapses | 1 | 1995 | 265 | 0.030 |
Why?
|
| Cell Differentiation | 1 | 1999 | 1458 | 0.030 |
Why?
|
| Mass Spectrometry | 1 | 2013 | 188 | 0.030 |
Why?
|
| Cysteine | 1 | 2013 | 135 | 0.030 |
Why?
|
| Erythrocytes | 1 | 1993 | 255 | 0.030 |
Why?
|
| Calbindin 1 | 3 | 1997 | 11 | 0.030 |
Why?
|
| Calbindins | 3 | 1997 | 19 | 0.030 |
Why?
|
| Oxidation-Reduction | 1 | 2013 | 373 | 0.030 |
Why?
|
| Models, Molecular | 2 | 1994 | 1286 | 0.030 |
Why?
|
| Electrophoresis, Polyacrylamide Gel | 1 | 1992 | 268 | 0.030 |
Why?
|
| Case-Control Studies | 1 | 2017 | 1805 | 0.030 |
Why?
|
| Adenoviridae Infections | 1 | 1972 | 15 | 0.030 |
Why?
|
| Immunologic Capping | 3 | 1980 | 14 | 0.030 |
Why?
|
| Fibroblasts | 1 | 1995 | 729 | 0.030 |
Why?
|
| Retroviridae Proteins | 2 | 1988 | 5 | 0.030 |
Why?
|
| Membranes, Artificial | 1 | 2011 | 40 | 0.030 |
Why?
|
| CD4 Antigens | 2 | 2002 | 83 | 0.030 |
Why?
|
| Consensus Sequence | 1 | 1991 | 64 | 0.030 |
Why?
|
| Biophysical Phenomena | 1 | 2011 | 120 | 0.030 |
Why?
|
| Microscopy, Atomic Force | 1 | 2011 | 52 | 0.030 |
Why?
|
| Indoles | 2 | 2004 | 318 | 0.030 |
Why?
|
| HIV Antibodies | 2 | 1988 | 25 | 0.030 |
Why?
|
| Biophysics | 1 | 2011 | 152 | 0.020 |
Why?
|
| Life Support Care | 1 | 1991 | 49 | 0.020 |
Why?
|
| HTLV-I Antigens | 1 | 1990 | 1 | 0.020 |
Why?
|
| Paraguay | 1 | 1990 | 3 | 0.020 |
Why?
|
| Nucleic Acid Conformation | 1 | 1992 | 332 | 0.020 |
Why?
|
| Mesocricetus | 2 | 1982 | 107 | 0.020 |
Why?
|
| Encephalomyelitis | 2 | 1983 | 6 | 0.020 |
Why?
|
| Leukoencephalopathy, Progressive Multifocal | 2 | 1983 | 13 | 0.020 |
Why?
|
| Lipid Bilayers | 1 | 2011 | 134 | 0.020 |
Why?
|
| Patch-Clamp Techniques | 1 | 2011 | 396 | 0.020 |
Why?
|
| Templates, Genetic | 1 | 1989 | 34 | 0.020 |
Why?
|
| Culture Techniques | 2 | 1985 | 91 | 0.020 |
Why?
|
| Cross-Sectional Studies | 1 | 2015 | 1621 | 0.020 |
Why?
|
| Dentinogenesis Imperfecta | 1 | 1979 | 2 | 0.020 |
Why?
|
| Osteogenesis Imperfecta | 1 | 1979 | 4 | 0.020 |
Why?
|
| Severity of Illness Index | 1 | 2015 | 1801 | 0.020 |
Why?
|
| Patient Participation | 1 | 1991 | 216 | 0.020 |
Why?
|
| Receptors, Metabotropic Glutamate | 1 | 2009 | 52 | 0.020 |
Why?
|
| United States | 2 | 2001 | 6672 | 0.020 |
Why?
|
| Histocompatibility Antigens Class II | 2 | 2000 | 158 | 0.020 |
Why?
|
| Species Specificity | 1 | 1990 | 678 | 0.020 |
Why?
|
| Virus Cultivation | 2 | 1982 | 20 | 0.020 |
Why?
|
| Serum Albumin | 2 | 1988 | 130 | 0.020 |
Why?
|
| beta-Galactosidase | 2 | 2000 | 71 | 0.020 |
Why?
|
| Immunoassay | 1 | 1988 | 92 | 0.020 |
Why?
|
| HIV | 1 | 1988 | 46 | 0.020 |
Why?
|
| Oligoclonal Bands | 2 | 1988 | 5 | 0.020 |
Why?
|
| Viral Envelope Proteins | 1 | 1988 | 94 | 0.020 |
Why?
|
| Follow-Up Studies | 1 | 2015 | 3640 | 0.020 |
Why?
|
| Retroviridae Infections | 2 | 1985 | 48 | 0.020 |
Why?
|
| Autoradiography | 1 | 1987 | 69 | 0.020 |
Why?
|
| Kinetics | 1 | 1989 | 1513 | 0.020 |
Why?
|
| Rosaniline Dyes | 2 | 1983 | 9 | 0.020 |
Why?
|
| Amyloidosis | 2 | 1995 | 115 | 0.020 |
Why?
|
| Sensitivity and Specificity | 2 | 2004 | 1991 | 0.020 |
Why?
|
| Rats, Sprague-Dawley | 2 | 2000 | 1219 | 0.020 |
Why?
|
| Cross Reactions | 1 | 1986 | 106 | 0.020 |
Why?
|
| Decision Making | 1 | 1991 | 642 | 0.020 |
Why?
|
| Virion | 1 | 1985 | 59 | 0.020 |
Why?
|
| Immunoglobulin Light Chains | 2 | 1983 | 86 | 0.020 |
Why?
|
| Interferons | 1 | 1986 | 133 | 0.020 |
Why?
|
| T-Lymphocytes | 3 | 1996 | 1195 | 0.020 |
Why?
|
| Genes, Dominant | 2 | 2002 | 117 | 0.020 |
Why?
|
| Togaviridae | 1 | 1985 | 1 | 0.020 |
Why?
|
| Togaviridae Infections | 1 | 1985 | 1 | 0.020 |
Why?
|
| Coronaviridae | 1 | 1985 | 4 | 0.020 |
Why?
|
| Marek Disease | 1 | 1985 | 2 | 0.020 |
Why?
|
| Scrapie | 1 | 1985 | 2 | 0.020 |
Why?
|
| Coronaviridae Infections | 1 | 1985 | 7 | 0.020 |
Why?
|
| Flavivirus | 1 | 1985 | 6 | 0.020 |
Why?
|
| Lactate dehydrogenase-elevating virus | 1 | 1985 | 7 | 0.020 |
Why?
|
| Immunoglobulin A | 1 | 1985 | 80 | 0.020 |
Why?
|
| Encephalomyocarditis virus | 1 | 1985 | 40 | 0.020 |
Why?
|
| Orthomyxoviridae Infections | 1 | 1985 | 46 | 0.020 |
Why?
|
| Ribonuclease T1 | 1 | 1984 | 7 | 0.020 |
Why?
|
| Antigen-Antibody Complex | 2 | 1981 | 87 | 0.020 |
Why?
|
| Freezing | 1 | 2004 | 33 | 0.020 |
Why?
|
| Albumins | 1 | 1985 | 133 | 0.020 |
Why?
|
| Aging | 2 | 1980 | 691 | 0.020 |
Why?
|
| CHO Cells | 1 | 2004 | 187 | 0.020 |
Why?
|
| Cytomegalovirus Infections | 1 | 1985 | 144 | 0.010 |
Why?
|
| False Positive Reactions | 1 | 2004 | 216 | 0.010 |
Why?
|
| Attitude | 2 | 1996 | 127 | 0.010 |
Why?
|
| Immunity | 1 | 1985 | 136 | 0.010 |
Why?
|
| Translocation, Genetic | 1 | 1985 | 265 | 0.010 |
Why?
|
| Silver Nitrate | 1 | 1983 | 3 | 0.010 |
Why?
|
| Distemper Virus, Canine | 1 | 1983 | 2 | 0.010 |
Why?
|
| Oligonucleotides | 1 | 1984 | 92 | 0.010 |
Why?
|
| Murine hepatitis virus | 1 | 1983 | 7 | 0.010 |
Why?
|
| Nucleic Acid Hybridization | 2 | 1985 | 245 | 0.010 |
Why?
|
| Concanavalin A | 2 | 1980 | 52 | 0.010 |
Why?
|
| MAP Kinase Signaling System | 1 | 2004 | 192 | 0.010 |
Why?
|
| Hypergammaglobulinemia | 1 | 1983 | 8 | 0.010 |
Why?
|
| Young Adult | 1 | 2015 | 5976 | 0.010 |
Why?
|
| Oligoribonucleotides | 1 | 1983 | 28 | 0.010 |
Why?
|
| Birds | 1 | 1985 | 157 | 0.010 |
Why?
|
| Immunity, Cellular | 1 | 1983 | 177 | 0.010 |
Why?
|
| Pepstatins | 1 | 1982 | 3 | 0.010 |
Why?
|
| HLA Antigens | 2 | 1983 | 232 | 0.010 |
Why?
|
| Antilymphocyte Serum | 1 | 1982 | 71 | 0.010 |
Why?
|
| Culture Media, Conditioned | 1 | 2002 | 104 | 0.010 |
Why?
|
| Coculture Techniques | 1 | 2002 | 164 | 0.010 |
Why?
|
| Mice, Nude | 1 | 1984 | 790 | 0.010 |
Why?
|
| Huntingtin Protein | 1 | 2001 | 10 | 0.010 |
Why?
|
| Trinucleotide Repeats | 1 | 2001 | 31 | 0.010 |
Why?
|
| SSPE Virus | 1 | 1981 | 2 | 0.010 |
Why?
|
| Chronic Disease | 2 | 1994 | 971 | 0.010 |
Why?
|
| Fluorescent Antibody Technique | 1 | 1982 | 316 | 0.010 |
Why?
|
| Cyclophosphamide | 1 | 1982 | 299 | 0.010 |
Why?
|
| Retrospective Studies | 1 | 2015 | 8489 | 0.010 |
Why?
|
| Antigens | 1 | 1982 | 228 | 0.010 |
Why?
|
| Microscopy, Electron | 1 | 1982 | 503 | 0.010 |
Why?
|
| Spastin | 1 | 2000 | 3 | 0.010 |
Why?
|
| Tunisia | 1 | 2000 | 8 | 0.010 |
Why?
|
| Acute Disease | 2 | 1994 | 826 | 0.010 |
Why?
|
| Hybridization, Genetic | 1 | 1982 | 104 | 0.010 |
Why?
|
| Subarachnoid Space | 1 | 2000 | 17 | 0.010 |
Why?
|
| Laser-Doppler Flowmetry | 1 | 2000 | 20 | 0.010 |
Why?
|
| Receptor, Interferon alpha-beta | 1 | 2000 | 20 | 0.010 |
Why?
|
| Receptors, Interferon | 1 | 2000 | 31 | 0.010 |
Why?
|
| CD8 Antigens | 1 | 2000 | 82 | 0.010 |
Why?
|
| Basilar Artery | 1 | 2000 | 41 | 0.010 |
Why?
|
| North America | 1 | 2000 | 180 | 0.010 |
Why?
|
| Transgenes | 1 | 2000 | 180 | 0.010 |
Why?
|
| Risk | 1 | 2001 | 674 | 0.010 |
Why?
|
| In Situ Hybridization | 1 | 2000 | 307 | 0.010 |
Why?
|
| Adenosine Triphosphatases | 1 | 2000 | 153 | 0.010 |
Why?
|
| Gene Frequency | 1 | 2001 | 677 | 0.010 |
Why?
|
| Cerebral Angiography | 1 | 2000 | 196 | 0.010 |
Why?
|
| Haplotypes | 1 | 2001 | 642 | 0.010 |
Why?
|
| Lymphocyte Activation | 2 | 1999 | 728 | 0.010 |
Why?
|
| Histocompatibility Antigen H-2D | 1 | 1999 | 5 | 0.010 |
Why?
|
| Cerebrovascular Disorders | 1 | 1980 | 143 | 0.010 |
Why?
|
| Dogs | 1 | 2000 | 685 | 0.010 |
Why?
|
| Cerebrovascular Circulation | 1 | 2000 | 212 | 0.010 |
Why?
|
| Leucine | 1 | 1999 | 67 | 0.010 |
Why?
|
| Mitochondria | 1 | 2002 | 535 | 0.010 |
Why?
|
| Rabbits | 3 | 1987 | 636 | 0.010 |
Why?
|
| Spinal Diseases | 1 | 1999 | 44 | 0.010 |
Why?
|
| Parainfluenza Virus 1, Human | 1 | 1978 | 1 | 0.010 |
Why?
|
| Radioimmunoassay | 3 | 1982 | 155 | 0.010 |
Why?
|
| Peptide Hydrolases | 1 | 1978 | 100 | 0.010 |
Why?
|
| Registries | 1 | 2001 | 702 | 0.010 |
Why?
|
| Endothelium, Vascular | 1 | 2000 | 435 | 0.010 |
Why?
|
| Spleen | 1 | 1999 | 430 | 0.010 |
Why?
|
| Electrophoresis, Agar Gel | 3 | 1982 | 49 | 0.010 |
Why?
|
| DNA, Complementary | 1 | 1998 | 393 | 0.010 |
Why?
|
| Rubella | 1 | 1977 | 3 | 0.010 |
Why?
|
| Cytopathogenic Effect, Viral | 1 | 1996 | 7 | 0.010 |
Why?
|
| Nuclear Proteins | 1 | 2001 | 696 | 0.010 |
Why?
|
| Temperature | 1 | 1978 | 396 | 0.010 |
Why?
|
| Cerebrospinal Fluid | 1 | 1996 | 32 | 0.010 |
Why?
|
| Blood | 1 | 1996 | 69 | 0.010 |
Why?
|
| Receptors, N-Methyl-D-Aspartate | 1 | 1997 | 87 | 0.010 |
Why?
|
| Cell Count | 1 | 1996 | 195 | 0.010 |
Why?
|
| Genes, Tumor Suppressor | 1 | 1997 | 157 | 0.010 |
Why?
|
| Dizocilpine Maleate | 1 | 1996 | 12 | 0.010 |
Why?
|
| Mercaptoethanol | 1 | 1996 | 8 | 0.010 |
Why?
|
| 6-Cyano-7-nitroquinoxaline-2,3-dione | 1 | 1996 | 14 | 0.010 |
Why?
|
| Tomography, X-Ray Computed | 1 | 1986 | 2601 | 0.010 |
Why?
|
| Dementia | 2 | 1988 | 187 | 0.010 |
Why?
|
| Tetrodotoxin | 1 | 1996 | 50 | 0.010 |
Why?
|
| Ascorbic Acid | 1 | 1996 | 37 | 0.010 |
Why?
|
| Costs and Cost Analysis | 1 | 1996 | 153 | 0.010 |
Why?
|
| Calcium Channels | 1 | 1997 | 182 | 0.010 |
Why?
|
| PrPSc Proteins | 1 | 1995 | 22 | 0.010 |
Why?
|
| Complement Fixation Tests | 2 | 1972 | 5 | 0.010 |
Why?
|
| Embryo, Mammalian | 1 | 1996 | 207 | 0.010 |
Why?
|
| Hemagglutination Inhibition Tests | 2 | 1972 | 37 | 0.010 |
Why?
|
| N-Methylaspartate | 1 | 1995 | 51 | 0.010 |
Why?
|
| Reference Values | 1 | 1996 | 674 | 0.010 |
Why?
|
| Trigeminal Nerve | 1 | 1995 | 18 | 0.010 |
Why?
|
| Injections, Intramuscular | 1 | 1995 | 62 | 0.010 |
Why?
|
| Insurance, Health | 1 | 1996 | 160 | 0.010 |
Why?
|
| Isoelectric Point | 2 | 1988 | 16 | 0.010 |
Why?
|
| Sleep Initiation and Maintenance Disorders | 1 | 1995 | 50 | 0.010 |
Why?
|
| Cell Cycle | 1 | 1997 | 502 | 0.010 |
Why?
|
| Tongue | 1 | 1995 | 57 | 0.010 |
Why?
|
| Hindlimb | 1 | 1995 | 89 | 0.010 |
Why?
|
| Neurons, Afferent | 1 | 1995 | 79 | 0.010 |
Why?
|
| Lymphocyte Transfusion | 1 | 1994 | 41 | 0.010 |
Why?
|
| Clone Cells | 2 | 1988 | 213 | 0.010 |
Why?
|
| Cerebrospinal Fluid Proteins | 2 | 1986 | 9 | 0.010 |
Why?
|
| Thalamus | 1 | 1995 | 132 | 0.010 |
Why?
|
| Cardiopulmonary Resuscitation | 1 | 1996 | 190 | 0.010 |
Why?
|
| Pneumoencephalography | 1 | 1973 | 3 | 0.010 |
Why?
|
| Haplorhini | 1 | 1973 | 81 | 0.010 |
Why?
|
| Patient Satisfaction | 1 | 1996 | 455 | 0.010 |
Why?
|
| Movement Disorders | 1 | 1973 | 44 | 0.010 |
Why?
|
| Muscular Atrophy, Spinal | 1 | 1992 | 24 | 0.010 |
Why?
|
| Headache | 1 | 1973 | 73 | 0.010 |
Why?
|
| Vision Disorders | 1 | 1973 | 75 | 0.010 |
Why?
|
| Hemagglutination Tests | 1 | 1972 | 11 | 0.010 |
Why?
|
| Immunoelectrophoresis | 2 | 1982 | 19 | 0.010 |
Why?
|
| Illinois | 1 | 1993 | 462 | 0.010 |
Why?
|
| Resuscitation Orders | 1 | 1991 | 62 | 0.010 |
Why?
|
| Liver Diseases | 1 | 1973 | 238 | 0.010 |
Why?
|
| Health Care Costs | 1 | 1993 | 238 | 0.010 |
Why?
|
| Antibodies | 1 | 1972 | 350 | 0.010 |
Why?
|
| Lymphoma, Non-Hodgkin | 1 | 1972 | 261 | 0.010 |
Why?
|
| Mental Disorders | 1 | 1973 | 371 | 0.010 |
Why?
|
| HIV Core Protein p24 | 1 | 1988 | 7 | 0.010 |
Why?
|
| Antigen-Antibody Reactions | 1 | 1988 | 23 | 0.010 |
Why?
|
| Risk Assessment | 1 | 1996 | 2261 | 0.010 |
Why?
|
| Electroencephalography | 1 | 1973 | 709 | 0.010 |
Why?
|
| Leukemia, Lymphoid | 1 | 1988 | 72 | 0.010 |
Why?
|
| Patient Education as Topic | 1 | 1991 | 351 | 0.010 |
Why?
|
| Genetic Markers | 1 | 1989 | 476 | 0.010 |
Why?
|
| Child, Preschool | 2 | 1988 | 3612 | 0.000 |
Why?
|
| Attitude of Health Personnel | 1 | 1993 | 636 | 0.000 |
Why?
|
| Paralysis | 1 | 1987 | 23 | 0.000 |
Why?
|
| Denervation | 1 | 1987 | 34 | 0.000 |
Why?
|
| Recurrence | 1 | 1989 | 1139 | 0.000 |
Why?
|
| Fatigue | 1 | 1987 | 174 | 0.000 |
Why?
|
| Injections, Spinal | 1 | 1986 | 44 | 0.000 |
Why?
|
| Drug Evaluation | 1 | 1986 | 141 | 0.000 |
Why?
|
| Sepharose | 1 | 1985 | 14 | 0.000 |
Why?
|
| Physicians | 1 | 1993 | 673 | 0.000 |
Why?
|
| Prognosis | 1 | 1993 | 3679 | 0.000 |
Why?
|
| Sheep | 1 | 1985 | 239 | 0.000 |
Why?
|
| Surveys and Questionnaires | 1 | 1993 | 2501 | 0.000 |
Why?
|
| Computer Simulation | 1 | 1989 | 1078 | 0.000 |
Why?
|
| Prospective Studies | 1 | 1991 | 4213 | 0.000 |
Why?
|
| T-Lymphocytes, Helper-Inducer | 1 | 1983 | 132 | 0.000 |
Why?
|
| Brain Chemistry | 1 | 1982 | 121 | 0.000 |
Why?
|
| Precipitin Tests | 1 | 1981 | 108 | 0.000 |
Why?
|
| Infant | 1 | 1988 | 3046 | 0.000 |
Why?
|
| Immunoglobulin Fab Fragments | 1 | 1982 | 81 | 0.000 |
Why?
|
| Nerve Tissue | 1 | 1981 | 8 | 0.000 |
Why?
|
| Densitometry | 1 | 1981 | 29 | 0.000 |
Why?
|
| Hydrogen-Ion Concentration | 1 | 1982 | 493 | 0.000 |
Why?
|
| Myasthenia Gravis | 1 | 1981 | 83 | 0.000 |
Why?
|
| Guinea Pigs | 1 | 1981 | 171 | 0.000 |
Why?
|
| T-Lymphocytes, Regulatory | 1 | 1983 | 295 | 0.000 |
Why?
|
| Rosette Formation | 1 | 1980 | 34 | 0.000 |
Why?
|
| Colchicine | 1 | 1980 | 23 | 0.000 |
Why?
|
| Mitogens | 1 | 1980 | 64 | 0.000 |
Why?
|
| Solubility | 1 | 1980 | 177 | 0.000 |
Why?
|
| Chromosome Disorders | 1 | 1980 | 114 | 0.000 |
Why?
|
| Agglutination | 1 | 1979 | 17 | 0.000 |
Why?
|
| Lupus Erythematosus, Systemic | 1 | 1981 | 206 | 0.000 |
Why?
|
| Chromosome Aberrations | 1 | 1980 | 387 | 0.000 |
Why?
|
| Occupations | 1 | 1973 | 26 | 0.000 |
Why?
|
| Epidemiologic Methods | 1 | 1973 | 59 | 0.000 |
Why?
|
| Zoonoses | 1 | 1973 | 26 | 0.000 |
Why?
|
| Canada | 1 | 1973 | 204 | 0.000 |
Why?
|
| Genotype | 1 | 1978 | 1851 | 0.000 |
Why?
|
| Rubella virus | 1 | 1972 | 2 | 0.000 |
Why?
|
| Arboviruses | 1 | 1972 | 3 | 0.000 |
Why?
|
| Seasons | 1 | 1973 | 223 | 0.000 |
Why?
|
| Herpesviridae | 1 | 1972 | 14 | 0.000 |
Why?
|
| Simian virus 40 | 1 | 1972 | 35 | 0.000 |
Why?
|
| Vaccinia virus | 1 | 1972 | 19 | 0.000 |
Why?
|
| Orthomyxoviridae | 1 | 1972 | 37 | 0.000 |
Why?
|
| Residence Characteristics | 1 | 1973 | 197 | 0.000 |
Why?
|
| Socioeconomic Factors | 1 | 1973 | 567 | 0.000 |
Why?
|
| Feeding Behavior | 1 | 1973 | 324 | 0.000 |
Why?
|
| Pan troglodytes | 1 | 1972 | 197 | 0.000 |
Why?
|